| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), ADAPY's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | Norry Elliot | Chief Medical Officer | Sell | 4,624 | $3.55 | $16,435.42 | -77.0% | |
| Jan 12, 2022 | Lunger John | Chief Patient Supply Officer | Sell | 4,846 | $3.55 | $17,222.21 | -73.5% | |
| Jan 12, 2022 | Bertrand William C Jr | Chief Operating Officer | Sell | 6,018 | $3.55 | $21,375.90 | -61.6% | |
| Jan 4, 2022 | Bertrand William C Jr | Chief Operating Officer | Sell | 3,490 | $4.06 | $14,184.06 | -37.3% | |
| Jan 4, 2022 | Lunger John | Chief Patient Supply Officer | Sell | 1,070 | $4.06 | $4,348.69 | -37.9% | |
| Jan 4, 2022 | Norry Elliot | Chief Medical Officer | Sell | 849 | $4.06 | $3,450.51 | -38.0% | |
| Jan 4, 2022 | Rawcliffe Adrian | Chief Executive Officer | Sell | 5,532 | $4.06 | $22,483.15 | -47.3% | |
| Sep 1, 2021 | Rawcliffe Adrian | Chief Executive Officer | Sell | 2,782 | $5.20 | $14,452.49 | -47.5% | |
| Aug 2, 2021 | Lunger John | Chief Patient Supply Officer | Sell | 2,939 | $3.58 | $10,535.73 | -37.6% | |
| Jul 2, 2021 | Lunger John | Chief Patient Supply Officer | Sell | 1,907 | $4.26 | $8,133.16 | -37.6% |